Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?

Marco CefalìIsabel ScalaGiuliana PavoneDaniel HelblingSaskia HussungRalph FritschCäcilia ReinerSoleen StockerDieter KoeberleMarc KisslingVito ChiancaFilippo Del Grande Sara De Dosso Stefania Maria Rita Rizzo

Published in: Cancers (2023)

This study suggests that the retrospective analysis of changes in body composition is unlikely to be useful to predict toxicity to gemcitabine-nab-paclitaxel.

Keyphrases

body composition
resistance training
bone mineral density
computed tomography
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
oxidative stress
magnetic resonance imaging
prognostic factors
peritoneal dialysis
contrast enhanced
drug induced
chemotherapy induced
dual energy